Abstract
Veterinarians play a pivotal role in public health control, in particular in the management of risks deriving from pharmacological treatments of food-producing animals. Veterinary medicinal products can represent a risk for animal health and welfare (side effects, decreased efficacy), for farmers and practitioners administering the drug, for consumers of food of animal origin (presence of residues, occurrence of antibiotic resistance) and for the environment. According to pending European guidelines, risk management starts from marketing authorisation that must be based on risk evaluation and can be denied when the risk/benefit ratio is not favourable considering the advantages for animal health and welfare and for safety of consumers. Veterinarians can prevent and control risks by using correct pharmacological criteria to choose and administer medicinal products and undertaking risk-based inspection of residues of drugs in food of animal origin. Moreover, a major tool for veterinarians to prevent and control drug-borne risk is “pharmacovigilance”. Risks for the environment are usually assessed during the pre-marketing approval process, however veterinarians, as risk managers, should educate farmers about correct drug handling and disposal, and periodically verify that suggested measures are applied.
References
Baker R., 2006. Health management with reduced antibiotic use. The US experience. Animal Biotechnology, 17, 195–205.
Barbosa J., Cruz C., Martins J., Silva J.M., Neves C., Alves C., Ramos F., Da Silveira M.I., 2005. Food poisoning by clenbuterol in Portugal. Food Additives and Contaminants, 22, 563–566.
Capleton A.C., Courage C., Rumsby P., Holmes P., Stutt E., Boxall A.B.A., Levy L.S., 2006. Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile. Toxicology Letters, 163, 213–223.
Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati L., 2006. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid cromatography-tandem mass spectrometry. Analytical Chemistry, 78, 8421–8429.
Gehring R., Baynes R.E., Riviere J.E., 2006. Application of risk assessment and management principles to the extralabel use of drugs in food-producing animals. Journal of Veterinary Pharmacology and Therapeutics, 29, 5–14.
George M.H., Cowman G.L., Tatum J.D., Smith G.C., 1997. Injection-site lesions in beef subprimals: incidence, palatability consequences, and economic impact. Compendium of Continuing Education for Practising Veterinarians, 19, S84–S93.
Grugel G. and Wallmann J., 2004. Antimicrobial resistance in bacteria from food-producing animals, risk management tools and strategies. Journal of Veterinary Medicine B, 51, 419–421.
Hirsch R., Ternes T., Haberer K., Kratz K.L., 1999. Occurrence of antibiotics in the aquatic environment. The Science of Total Environment, 225, 109–118.
Jacobs-Reitsma W.F., Kan C.A., Bolder N.M., 1994. The induction of quinolone resistance in Campylobacter bacteria in broilers by quinolone treatment. Letters in Applied Microbiology, 19, 228–231.
Jensen H.M., 2006. Health management with reduced antibiotic use. Experiences of a Danish pig Vet. Animal Biotechnology, 17, 189–194.
Keck G. and Ibrahim C., 2001. Veterinary pharmacovigilance: between regulation and science. Journal of Veterinary Pharmacology and Therapeutics, 24, 369–373.
Kleiner D.K., Stanley E.K., Ward P.L.M., 2007. Development of in vitro antimicrobial resistance in bacteria exposed to residual level exposures of antimicrobial drugs, pesticides and veterinary drugs. Chemotherapy, 53, 132–136.
Mumford E.L. and Kihm U., 2006. Integrated risk reduction along the food chain. Annals of the New York Academy of Sciences, 1081, 147–152.
Nelson J.M., Chiller T.M., Powers J.H., Angulo F.J., 2007. Fluoroquinolone resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Food Safety, 44, 977–980.
Passantino A., 2007. Ethical aspects for veterinarians regarding antimicrobial drug use in Italy. International Journal of Antimicrobial Agents, 29, 240–244.
Reeves P.T., 2007. Residues of veterinary drugs at injection sites. Journal of Veterinary Pharmacology and Therapeutics, 30, 1–17.
Roeber D.L., Cannell R.C., Belk K.E., Scanga J.A., Cowman G.L., Smith G.C., 2001. Incidence on injection site lesions in beef top sirloin butts. Journal of Animal Science, 79, 2615–2618.
Ungemach F., Muller-Bahrdt D., Abraham G., 2006. Guidelines for prudent use of antimicrobials and their implications on antibiotic usage in veterinary medicine. International Journal of Medical Microbiology, 296, 33–38.
van den Bogaard A.E. and Stobberingh E.E., 2000. Epidemiology of resistance to antibiotics. International Journal of Antimicrobial Agents, 14, 327–335.
Veenhuizen M.F., Wright T.J., McManus R.F., Owens J.G., 2006. Analysis of reports of human exposure to Micotil 300 (tilmicosin injection). Journal of Veterinary Medical Association, 229, 1737–1742.
Zilles J., Shimada T., Jindai A., Robert M., Raskin L., 2005. Presence of macrolide-lincosamide-streptogramin B and tetracycline antimicrobials in swine waste treatment process and amended soil. Water Environment Research, 77, 57–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Girardi, C., Odore, R. Pharmacological treatments and risks for the food chain. Vet Res Commun 32 (Suppl 1), 11–18 (2008). https://doi.org/10.1007/s11259-008-9083-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-008-9083-5